UHS: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net income attributable to uhs	1,063,345	684,240	321,628	826,062
Depreciation & amortization	455,409	300,349	148,345	438,050
Loss (gain) on sales of assets and businesses	-2,833	-2,833	-	5,124
Costs related to extinguishment of debt	-	-	-	3,158
Stock-based compensation expense	70,586	45,707	21,595	72,727
Accounts receivable	294,210	92,636	218,374	-11,703
Accrued interest	-7,052	4,532	-11,086	1,762
Accrued and deferred income taxes	39,287	55,913	-88,641	10,949
Other working capital accounts	-20,415	-25,324	42,824	-1,329
Medicare accelerated payments and deferred cares act and other grants	-	-	-	0
Other assets and deferred charges	29,629	22,404	489	5,621
Other, net	19,114	16,143	3,811	25,732
Accrued insurance expense, net of commercial premiums paid	177,054	94,696	47,334	175,104
Payments made in settlement of self-insurance claims	-	-	20,705	121,745
Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements	162,978	84,781	-	-
Net cash provided by operating activities	1,289,704	909,026	360,048	1,408,664
Property and equipment additions	733,932	505,040	239,026	697,865
Proceeds received from sales of assets and businesses	2,980	2,980	-	30,219
Acquisition of businesses and property	47,772	8,314	8,314	0
Outflows from foreign exchange contracts that hedge our net u.k. investment	49,351	66,402	23,695	35,667
Costs incurred for purchase and development of enterprise resource planning application	18,676	-	-	-
Decrease in capital reserves of commercial insurance subsidiary	-100	462	264	-197
Net cash used in investing activities	-846,651	-577,238	-271,299	-703,116
Repayments of long-term debt	27,791	18,548	9,113	2,471,515
Additional borrowings	208,986	94,601	152,454	2,210,248
Financing costs	382	-	-	9,992
Repurchase of common shares	615,941	378,542	223,385	420,588
Dividends paid	38,902	26,434	13,534	40,302
Issuance of common stock	12,119	8,137	3,658	10,864
Profit distributions to noncontrolling interests	10,409	9,621	5,912	5,791
Purchase (sale) of ownership interests by (from) minority member	18,728	11,336	4,412	8,959
Net cash used in financing activities	-453,592	-319,071	-91,420	-718,117
Effect of exchange rate changes on cash, cash equivalents and restricted cash	2,390	3,931	1,645	2,696
Decrease in cash, cash equivalents and restricted cash	-8,149	16,648	-1,026	-9,873
Cash and cash equivalents at beginning of period	224,752	224,752	224,752	214,470
Cash and cash equivalents at end of period	216,603	241,400	223,726	204,597

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

UHS: the cashflow